Premium
How to select our treatments?
Author(s) -
CREUZOT C
Publication year - 2013
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2013.2214.x
Subject(s) - medicine , macular edema , intensive care medicine , glaucoma , optometry , ophthalmology , retinal
The analysis of associated circumstances to macular edema will help the clinician to select one among the different therapeutic options of macular edema (ME). The duration of ME, the efficacy of previous treatments, the ability of the patient to be examined regularly will influence this choice. The different options are grid laser, antiVEGF agents, steroids. Associated risk factors like severe glaucoma or lens status also need to be considered. The control of systemic conditions remain a key issue. The strategy can change during the follow‐up according to the efficacy and the recurrences observed with the treatments.Commercial interest